Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ARANESP for Haemoglobin decreased: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where ARANESP was used for Haemoglobin decreased.

Most Reported Side Effects for ARANESP

Side Effect Reports % Deaths Hosp.
Death 2,018 65.7% 2,018 50
Investigation 403 13.1% 28 401
Hospitalisation 289 9.4% 11 288
Dialysis 35 1.1% 0 9
Haemoglobin decreased 32 1.0% 1 11
Aplasia pure red cell 26 0.9% 1 14
Transfusion 18 0.6% 1 11
Dyspnoea 17 0.6% 2 10
Haemoglobin abnormal 17 0.6% 1 7
Anaemia 16 0.5% 2 8
Fatigue 16 0.5% 1 10
Pneumonia 15 0.5% 4 14
Drug ineffective 14 0.5% 0 4
Asthenia 13 0.4% 2 9
Malaise 13 0.4% 1 8

Other Indications for ARANESP

Nephrogenic anaemia (1,740) Anaemia (747) Product used for unknown indication (347) Myelodysplastic syndrome (166) Renal failure chronic (56)

Other Drugs Used for Haemoglobin decreased

ERYTHROPOIETIN (128) METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA (65) DARBEPOETIN ALFA (51) FERRIC CARBOXYMALTOSE (47) IRON (34) PREDNISONE (33) EPOETIN ALFA-EPBX (26) IRON SUCROSE (21) CYCLOSPORINE (20) FERROUS (19)

Related Pages

ARANESP Full Profile All Haemoglobin decreased Drugs ARANESP Demographics ARANESP Timeline